MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...

Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...

The GW Ranch project approved on 8,000 windswept acres of West Texas will look like many of the other data centers that have sprung up across the country to support Silicon Valley’s ambitions for ...

Jennifer Nelson writes about all things money--personal finance, investing, saving, credit cards and insurance for numerous publications including AARP, Next Avenue, Credit Karma, Real SImple, Citi ...

The partnership gives MSD access to datasets, registries, biorepositories, AI tools, analytics, and scalable solutions via Mayo Clinic. Credit: ART STOCK CREATIVE / Shutterstock.com. Merck & Co (MSD) ...

A state abuse survivor is sickened she may have to repay welfare supports that kept her afloat while she was waiting for ACC compensation. It comes as a lawyer and researcher flags his concerns the ...